226 related articles for article (PubMed ID: 28362236)
21. Glioblastoma treated with postoperative radio-chemotherapy: prognostic value of apparent diffusion coefficient at MR imaging.
Yamasaki F; Sugiyama K; Ohtaki M; Takeshima Y; Abe N; Akiyama Y; Takaba J; Amatya VJ; Saito T; Kajiwara Y; Hanaya R; Kurisu K
Eur J Radiol; 2010 Mar; 73(3):532-7. PubMed ID: 19250783
[TBL] [Abstract][Full Text] [Related]
22. Role of PROPELLER diffusion-weighted imaging and apparent diffusion coefficient in the evaluation of pituitary adenomas.
Mahmoud OM; Tominaga A; Amatya VJ; Ohtaki M; Sugiyama K; Sakoguchi T; Kinoshita Y; Takeshima Y; Abe N; Akiyama Y; El-Ghoriany AI; Abd Alla AK; El-Sharkawy MA; Arita K; Kurisu K; Yamasaki F
Eur J Radiol; 2011 Nov; 80(2):412-7. PubMed ID: 20580505
[TBL] [Abstract][Full Text] [Related]
23. Role of diffusion-weighted MR in differential diagnosis of intracranial cystic lesions.
Bükte Y; Paksoy Y; Genç E; Uca AU
Clin Radiol; 2005 Mar; 60(3):375-83. PubMed ID: 15710142
[TBL] [Abstract][Full Text] [Related]
24. Outcome prediction in patients with glioblastoma by using imaging, clinical, and genomic biomarkers: focus on the nonenhancing component of the tumor.
Jain R; Poisson LM; Gutman D; Scarpace L; Hwang SN; Holder CA; Wintermark M; Rao A; Colen RR; Kirby J; Freymann J; Jaffe CC; Mikkelsen T; Flanders A
Radiology; 2014 Aug; 272(2):484-93. PubMed ID: 24646147
[TBL] [Abstract][Full Text] [Related]
25. Apparent diffusion coefficient of glial neoplasms: correlation with fluorodeoxyglucose-positron-emission tomography and gadolinium-enhanced MR imaging.
Holodny AI; Makeyev S; Beattie BJ; Riad S; Blasberg RG
AJNR Am J Neuroradiol; 2010 Jun; 31(6):1042-8. PubMed ID: 20150307
[TBL] [Abstract][Full Text] [Related]
26. Predicting survival in glioblastomas using diffusion tensor imaging metrics.
Saksena S; Jain R; Narang J; Scarpace L; Schultz LR; Lehman NL; Hearshen D; Patel SC; Mikkelsen T
J Magn Reson Imaging; 2010 Oct; 32(4):788-95. PubMed ID: 20882608
[TBL] [Abstract][Full Text] [Related]
27. Prognostic value of preoperative diffusion restriction in glioblastoma.
Labbène E; Mahmoud M; Marrakchi-Kacem L; Ben Hamouda M
Tunis Med; 2024 Feb; 102(2):94-99. PubMed ID: 38567475
[TBL] [Abstract][Full Text] [Related]
28. [Value of diffusion-weighted imaging in the evaluation of adnexal tumors].
Roussel A; Thomassin-Naggara I; Darai E; Marsault C; Bazot M
J Radiol; 2009 May; 90(5 Pt 1):589-96. PubMed ID: 19503047
[TBL] [Abstract][Full Text] [Related]
29. Ultra-high b-value DWI accurately identifies isocitrate dehydrogenase genotypes and tumor subtypes of adult-type diffuse gliomas.
Wang X; Shu X; He P; Cai Y; Geng Y; Hu X; Sun Y; Xiao H; Zheng W; Song Y; Xue Y; Jiang R
Eur Radiol; 2024 Mar; ():. PubMed ID: 38528135
[TBL] [Abstract][Full Text] [Related]
30. AI-based classification of three common malignant tumors in neuro-oncology: A multi-institutional comparison of machine learning and deep learning methods.
Bathla G; Dhruba DD; Soni N; Liu Y; Larson NB; Kassmeyer BA; Mohan S; Roberts-Wolfe D; Rathore S; Le NH; Zhang H; Sonka M; Priya S
J Neuroradiol; 2024 May; 51(3):258-264. PubMed ID: 37652263
[TBL] [Abstract][Full Text] [Related]
31. Magnetic resonance findings of primary central nervous system T-cell lymphoma in immunocompetent patients.
Kim EY; Kim SS
Acta Radiol; 2005 Apr; 46(2):187-92. PubMed ID: 15902895
[TBL] [Abstract][Full Text] [Related]
32. Diffusion tensor imaging in glioblastoma multiforme and brain metastases: the role of p, q, L, and fractional anisotropy.
Wang W; Steward CE; Desmond PM
AJNR Am J Neuroradiol; 2009 Jan; 30(1):203-8. PubMed ID: 18842762
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic value of whole body diffusion weighted imaging for screening primary tumors of patients with metastases.
Gu TF; Xiao XL; Sun F; Yin JH; Zhao H
Chin Med Sci J; 2008 Sep; 23(3):145-50. PubMed ID: 18853848
[TBL] [Abstract][Full Text] [Related]
34. Tumor regrowth between surgery and initiation of adjuvant therapy in patients with newly diagnosed glioblastoma.
Pirzkall A; McGue C; Saraswathy S; Cha S; Liu R; Vandenberg S; Lamborn KR; Berger MS; Chang SM; Nelson SJ
Neuro Oncol; 2009 Dec; 11(6):842-52. PubMed ID: 19229057
[TBL] [Abstract][Full Text] [Related]
35. Distinct tumor signatures using deep learning-based characterization of the peritumoral microenvironment in glioblastomas and brain metastases.
Samani ZR; Parker D; Wolf R; Hodges W; Brem S; Verma R
Sci Rep; 2021 Jul; 11(1):14469. PubMed ID: 34262079
[TBL] [Abstract][Full Text] [Related]
36. Peritumoral diffusion tensor imaging of high-grade gliomas and metastatic brain tumors.
Lu S; Ahn D; Johnson G; Cha S
AJNR Am J Neuroradiol; 2003 May; 24(5):937-41. PubMed ID: 12748097
[TBL] [Abstract][Full Text] [Related]
37. MR imaging of metronidazole-induced encephalopathy: lesion distribution and diffusion-weighted imaging findings.
Kim E; Na DG; Kim EY; Kim JH; Son KR; Chang KH
AJNR Am J Neuroradiol; 2007 Oct; 28(9):1652-8. PubMed ID: 17885234
[TBL] [Abstract][Full Text] [Related]
38. MRI features of neuronal intranuclear inclusion disease, combining visual and quantitative imaging investigations.
Zhang Z; Xu Q; Li J; Zhang C; Bai Z; Chai X; Xu K; Xiao C; Chen F; Liu T; Gu H; Xing W; Lu G; Zhang Z
J Neuroradiol; 2024 May; 51(3):274-280. PubMed ID: 37758172
[TBL] [Abstract][Full Text] [Related]
39. Diffusion-weighted imaging in patients with progressive multifocal leukoencephalopathy.
Cosottini M; Tavarelli C; Del Bono L; Doria G; Giannelli M; De Cori S; Michelassi MC; Bartolozzi C; Murri L
Eur Radiol; 2008 May; 18(5):1024-30. PubMed ID: 18324406
[TBL] [Abstract][Full Text] [Related]
40. Diffusion-weighted imaging of metastatic brain tumors: comparison with histologic type and tumor cellularity.
Hayashida Y; Hirai T; Morishita S; Kitajima M; Murakami R; Korogi Y; Makino K; Nakamura H; Ikushima I; Yamura M; Kochi M; Kuratsu JI; Yamashita Y
AJNR Am J Neuroradiol; 2006 Aug; 27(7):1419-25. PubMed ID: 16908550
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
